fda - Search News

News

FDA Approves 1st Twice-a-Year HIV Prevention Shot

FDA Approves First Twice-a-Year HIV Prevention Shot

FRIDAY, June 20, 2025 (HealthDay News) — A new shot to prevent HIV infection has just been approved — and it only needs to be taken twice a year. On Wednesday, the U.S. Food and Drug Administration (FDA) approved lenacapavir, a long-acting injection that was shown to be nearly 100% effective in clinical trials.

USA TODAY on MSN · 1d

FDA approves new twice-yearly HIV shot. What to know

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

CBS News on MSN · 2d

HIV prevention drug lenacapavir approved by FDA as twice-yearly injection

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo from company Gilead Sciences, remained HIV negative.

Supreme Court, FDA and Tobacco Companies

Associated Press News on MSN · 21h

Supreme Court widens court options for vaping companies pushing back against FDA rules

The Supreme Court sided with e-cigarette companies on Friday in a ruling making it easier to sue over Food and Drug Administration decisions blocking their products from the multibillion-dollar vaping market.

The Washington Post on MSN · 1d

R.J. Reynolds wins at Supreme Court on how to challenge FDA vape rulings

The case focused on venue-shopping, and whether the tobacco company could appeal a Food and Drug Administration decision in the conservative 5th Circuit.

MarketWatch · 23h

Supreme Court Ruling on Where Tobacco Companies Can Sue FDA Is Disappointing, but Doesn't Speak to Merits of Decisions Against Flavored E-Cigarettes

The U.S. Supreme Court today ruled that e-cigarette manufacturers can file lawsuits challenging FDA marketing denial orders for e-cigarettes outside of the appellate court circuits where they are based.

2don MSN

Ginger Beer Recall Update as FDA Issues Highest Risk Warning

Rachel's Ginger Beer issued a voluntary recall for its "Cucumber x Tarragon Ginger Beer" in November last year due to ...

18h

FDA Approves Once-Monthly Andembry for Hereditary Angioedema

By Lori Solomon HealthDay ReporterFRIDAY, June 20, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...

STAT22h

Disagreements over Duchenne therapy, management style may have led to ouster of key FDA official

The ouster of the FDA's chief regulator of cell and gene therapies came immediately after a disagreement with her boss over a ...

1don MSN

Threat in your medicine cabinet: The FDA’s gamble on America’s drugs

The FDA didn’t routinely test the medications for quality problems or use its vast repository of drug-related complaints to ...

FDA announces sweeping changes to speed up the drug review process

An FDA pilot program, known as the Commissioner’s Priority Voucher program, could drastically change the way pharmaceutical ...

1don MSN

US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list

By Diana Novak Jones (Reuters) -A federal judge has rejected a bid by compounding pharmacies to allow them to continue making ...

23hon MSN

Gene Therapy Stocks Fall as FDA Pushes Out Another Top Regulator

The HHS said center directors deserve to be supported by managers aligned with aggressive goals “to expeditiously advance ...

STAT22h

As AI device market grows, FDA’s accounting goes silent

As the market for AI enabled medical devices grows, experts say there is less transparency around device approvals.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

News

FDA Approves 1st Twice-a-Year HIV Prevention Shot

Supreme Court, FDA and Tobacco Companies

Related topics